DCM Advisors’s Amgen AMGN Stock Holding History

DCM Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,300	Closed	-$662K	–	81
2023 Q4	$662K	Buy	+2,300	New	+$627K	0.24%	60
2022 Q4	–	Sell	-3,021	Closed	-$681K	–	75
2022 Q3	$681K	Sell	3,021 -374	-11%	-$90.7K	0.34%	75
2022 Q2	$827K	Buy	+3,395	New	+$832K	0.36%	78

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

DCM Advisors's AMGN Position: Q1 2024 in Review

DCM Advisors sold out of Amgen (AMGN) in Q1 2024, closing a stake of 2,300 shares — an estimated $662K sold.

DCM Advisors first reported a position in AMGN in Q2 2022 and held it in 3 quarters. The position peaked at $827K in Q2 2022. 2,716 funds tracked by Wall St. Rank hold AMGN as of Q1 2024.

DCM Advisors reported no remaining Amgen position as of Q1 2024 after selling out during the quarter.
DCM Advisors sold 2,300 Amgen shares in Q1 2024, an estimated $662K.
DCM Advisors first reported a position in Amgen in Q2 2022 and held it in 3 quarters.
DCM Advisors's Amgen position peaked at $827K in Q2 2022.
2,716 funds tracked by Wall St. Rank held Amgen as of Q1 2024.

Based on DCM Advisors's 13F filing for Q1 2024, filed 16 May 2024.